Perrigo | Omløpsmidler

Current Assets Endring Dato
AbbVie USD 38.87B 5.65B 2024-03
Abbott USD 22.38B 1.13B 2024-03
Bayer EUR 40.17B 2.61B 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Catalent USD 2.52B 47M 2024-03
Corcept Therapeutics USD 503.37M 44.73M 2024-03
Dr.Reddys Laboratories INR 238.48B 21.08B 2023-12
Eli Lilly USD 25.19B 2.18B 2024-03
J&J USD 57B 3.3B 2024-03
Merck USD 31.44B 509M 2024-03
Nestle CHF 30.86B 2.46B 2023-12
Pacira USD 543.11M 33.12M 2024-03
Perrigo USD 2.81B 26.5M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Prestige Brands USD 375.04M 18.74M 2024-03
Reckitt Benckiser GBP 5.3B 303M 2023-12
Supernus Pharmaceuticals USD 544.32M 51.21M 2024-03
Teva Pharmaceutical Industries USD 12.3B 188M 2024-03
Xeris Pharmaceuticals USD 173.28M 17.02M 2024-03
Zoetis USD 6.36B 16M 2024-03



Perrigo Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.